Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas (MAINTAIN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00877214
Recruitment Status : Active, not recruiting
First Posted : April 7, 2009
Last Update Posted : April 19, 2019
Sponsor GmbH
Information provided by (Responsible Party):
Jurgen Barth, University of Giessen

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : April 2022
Estimated Study Completion Date : April 2022